Risk-Benefit Balancing In Approvals.
Introduction
Risk-benefit balancing in biotechnology approvals is the process of deciding whether the expected advantages of a biotechnology product or activity justify its potential risks to human health, the environment, and society. It is especially important when approving genetically modified (GM) crops, gene therapies, vaccines, and other biotechnology innovations.
The process requires regulators to examine the nature and likelihood of harm, the seriousness of possible consequences, the scientific evidence supporting claimed benefits, and the availability of safer alternatives. Benefits may include improved crop productivity, treatment of serious diseases, or reduced use of harmful chemicals. Risks may include unintended biological effects, environmental damage, or adverse health consequences.
In India, risk-benefit balancing is governed by statutory frameworks such as the Environment (Protection) Act, 1986, and the 1989 Rules regulating genetically engineered organisms. It is also shaped by constitutional protections under Article 21 and the precautionary principle. Importantly, economic or technological benefits cannot automatically justify a serious risk that has not been adequately assessed.
Important Case Laws
1. Gene Campaign v. Union of India, 2024 INSC 545
The Supreme Court considered the conditional environmental approval of genetically modified mustard (DMH-11). The case involved the balance between agricultural development and food security on one side, and potential risks to health, biodiversity, and the environment on the other.
The Court recognised that GMO risk assessment must be scientifically sound, transparent, and conducted on a case-by-case basis. It also examined whether uncertainties could be addressed through further information, risk-management measures, and monitoring. The judges delivered separate opinions and differed on the validity of the approval; the issue was referred for fresh consideration. Therefore, the judgment is not a unanimous endorsement or rejection of GM mustard.
Manupatra eNewsLine+1
2. Vellore Citizens’ Welfare Forum v. Union of India, (1996) 5 SCC 647
The Supreme Court recognised the precautionary principle as part of Indian environmental law. It held that where serious or irreversible harm is threatened, lack of complete scientific certainty cannot justify delaying preventive measures.
This limits risk-benefit balancing: anticipated economic benefits cannot automatically outweigh a credible threat of serious environmental damage. Regulators must consider prevention, mitigation, and the consequences of uncertainty.
Supreme Court
3. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718
The Supreme Court emphasised the role of scientific expertise in environmental decision-making, particularly where risks are complex or uncertain. The case supports expert review and evidence-based evaluation before approving activities that may cause environmental harm.
Principles of Balancing
A sound approval process should consider:
Expected benefits: Whether the product provides a meaningful health, agricultural, or scientific advantage.
Risk severity and likelihood: Both the probability and possible consequences of harm.
Alternatives: Whether safer or established options are available.
Uncertainty: Whether missing evidence requires further testing or monitoring.
Proportionality: Whether the remaining risk is justified by the expected benefit.
Conclusion
Risk-benefit balancing is essential to lawful and responsible biotechnology approvals. It requires regulators to assess benefits and risks together, rather than treating innovation or precaution as an absolute priority. Gene Campaign demonstrates the importance of transparent, case-specific biosafety assessment, while Vellore Citizens’ Welfare Forum establishes that serious environmental threats cannot be ignored because scientific certainty is incomplete. A.P. Pollution Control Board v. Nayudu reinforces the role of expert evidence. The ultimate objective is to permit beneficial innovation while maintaining adequate safeguards for health, the environment, and future generations.

comments